151. Connection Between CDC20 Expression and Hepatocellular Carcinoma Prognosis
- Author
-
Xianjun Zhang, Jian Dou, Guang Li, Xinguo Li, Hongbing Bao, Ning Li, Xianfeng Zhang, and Hengli Li
- Subjects
Oncology ,Male ,medicine.medical_specialty ,Carcinoma, Hepatocellular ,Cdc20 Proteins ,CDC20 ,030204 cardiovascular system & hematology ,Cell division cycle ,03 medical and health sciences ,0302 clinical medicine ,Lab/In Vitro Research ,Internal medicine ,Biomarkers, Tumor ,Medicine ,Humans ,Stage (cooking) ,Neoplasm Metastasis ,neoplasms ,Neoplasm Staging ,Proportional Hazards Models ,business.industry ,Proportional hazards model ,Hazard ratio ,Liver Neoplasms ,General Medicine ,Middle Aged ,medicine.disease ,Prognosis ,Survival Analysis ,Confidence interval ,digestive system diseases ,Up-Regulation ,Gene Expression Regulation, Neoplastic ,030220 oncology & carcinogenesis ,Hepatocellular carcinoma ,Biomarker (medicine) ,Female ,business - Abstract
BACKGROUND Hepatocellular carcinoma (HCC) occurs frequently in China, with high morbidity and mortality. Cell division cycle 20 homolog (CDC20) is reportedly related to many cancers. In this study, we discuss a potential link of CDC20 expression to HCC patients' prognoses. MATERIAL AND METHODS Quantitative real-time polymerase chain reaction (qRT-PCR) was performed to assess CDC20 expression in HCC and the paired noncancerous tissues. Chi-square analysis was used to assess potential association of CDC20 expression with clinicopathologic profiles among HCC patients. The overall survival for HCC patients with different CDC20 expressions was assessed using the Kaplan-Meier method. To evaluate the prognostic value for HCC patients, Cox regression analyses were performed. RESULTS The expression of CDC20 was elevated among HCC specimens compared with adjacent noncancerous ones (P
- Published
- 2021